TheraSource

company

About

TheraSource is a growing biotech company

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2004
Number Of Employee
11 - 50
Operating Status
Active

TheraSource is a growing biotech company founded in 2004 and located in the Greater New York area. Our mission is to develop novel anti-inflammatory therapeutics for the treatment of human diseases. Our founder and scientists have demonstrated the efficacy of several newly-discovered molecules in preclinical studies of various medical conditions including ischemic acute kidney injury (AKI), inflammatory bowel disease (IBD), acute ischemic stroke, acute radiation syndrome, shock and sepsis, leading to >250 peer-reviewed publications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3M
TheraSource has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on May 14, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 14, 2016 Grant $3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
TheraSource is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant